Skip to content
bluejethealthcare.com
Home
About Us
At A Glance
Facilities
History
Sustainability
News And Media
Business Segments
Integrated Contrast Media Intermediate Manufacturer
Saccharin & it’s salts
Niche pharmaceutical intermediates & API
CDMO-CMO
Capabilities
EHS
Reaction Capabilities
R & D Capabilities
Manufacturing Capabilities
Contact
Careers
Investor Relations
Notices
Investor Presentation
Stock Exchange Communication
Financial information
Annual Report
Annual Return
Corporate Governance
Board of Directors
Board Committees
Governance Policies
Familiarization Programmes
Prospectus
Investors Contact
Regulation 46 SEBI LODR
Shareholding Pattern
Tax Exemption Registration
Menu
Home
About Us
At A Glance
Facilities
History
Sustainability
News And Media
Business Segments
Integrated Contrast Media Intermediate Manufacturer
Saccharin & it’s salts
Niche pharmaceutical intermediates & API
CDMO-CMO
Capabilities
EHS
Reaction Capabilities
R & D Capabilities
Manufacturing Capabilities
Contact
Careers
Investor Relations
Notices
Investor Presentation
Stock Exchange Communication
Financial information
Annual Report
Annual Return
Corporate Governance
Board of Directors
Board Committees
Governance Policies
Familiarization Programmes
Prospectus
Investors Contact
Regulation 46 SEBI LODR
Shareholding Pattern
Tax Exemption Registration
Financial & Audit Report
Financial & Audit Report
Financial & Audit Report of FY 2022-23
Scroll to Top
